These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 21934521

  • 1. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L, Xing W, Xun H, Gui-fu W, Cheng-heng H, Zhi-min D.
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [Abstract] [Full Text] [Related]

  • 2. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y, Jiang Y, Fu X, Cai J, Wang Y, Li W, Gu X, Xing K, Bai S, Bi X.
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [Abstract] [Full Text] [Related]

  • 3. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR.
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [Abstract] [Full Text] [Related]

  • 4. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T, Kakuta T, Yonetsu T, Takahashi K, Yamamoto G, Iesaka Y, Fujiwara H, Isobe M.
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [Abstract] [Full Text] [Related]

  • 5. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K, Kawasaki D, Oka K, Akahori H, Iwasaku T, Fukunaga M, Eguchi A, Sawada H, Masutani M, Lee-Kawabata M, Tsujino T, Ohyanagi M, Masuyama T.
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [Abstract] [Full Text] [Related]

  • 6. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F, Pasceri V, Marazzi G, Rosano G, Greco C, Gaudio C.
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [Abstract] [Full Text] [Related]

  • 7. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
    Aslanabadi N, Safaie N, Asgharzadeh Y, Houshmand F, Ghaffari S, Garjani A, Dousti S, Hamishehkar H, Entezari-Maleki T.
    Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
    [Abstract] [Full Text] [Related]

  • 8. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM, Habbab MA, Sobki SH, Ferns GA.
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [Abstract] [Full Text] [Related]

  • 9. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.
    Auguadro C, Manfredi M, Scalise F, Mortara A, Specchia G.
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):416-21. PubMed ID: 16721204
    [Abstract] [Full Text] [Related]

  • 10. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures.
    Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA.
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():764-9. PubMed ID: 11085620
    [Abstract] [Full Text] [Related]

  • 11. Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.
    Davlouros PA, Arseniou A, Hahalis G, Chiladakis J, Mazarakis A, Damelou A, Karakantza M, Paliogianni F, Karogiannis N, Alexopoulos D.
    Am Heart J; 2009 Oct; 158(4):585-91. PubMed ID: 19781418
    [Abstract] [Full Text] [Related]

  • 12. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J.
    Am J Cardiol; 1999 Jul 01; 84(1):51-7. PubMed ID: 10404851
    [Abstract] [Full Text] [Related]

  • 13. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO.
    Am Heart J; 2003 Mar 01; 145(3):522-8. PubMed ID: 12660677
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of real-time myocardial perfusion imaging to evaluate alterations of myocardial blood flow in patients with stable angina pectoris undergoing elective percutaneous coronary interventions.
    Korosoglou G, Geiger B, Hansen A, Hardt SA, Giannitsis E, Selter C, Katus HA, Kuecherer H.
    Am J Cardiol; 2005 Oct 01; 96(7):885-91. PubMed ID: 16188510
    [Abstract] [Full Text] [Related]

  • 15. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK.
    JACC Cardiovasc Interv; 2008 Aug 01; 1(4):415-23. PubMed ID: 19463339
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ, Hu WK, Liu YY, Shi DM, Cheng WJ, Guo YH, Yang Q, Zhao YX, Zhou YJ.
    Can J Cardiol; 2014 Jan 01; 30(1):96-101. PubMed ID: 24365194
    [Abstract] [Full Text] [Related]

  • 18. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP, Brancati M, Burzotta F, Porto I, Trani C, De Vita M, Todaro D, Giammarinaro M, Leone AM, Niccoli G, Andreotti F, Mazzari MA, Schiavoni G, Crea F.
    J Cardiovasc Med (Hagerstown); 2009 Mar 01; 10(3):245-51. PubMed ID: 19262211
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS, Zhao XJ, Ma BX, Wang Z.
    J Biol Regul Homeost Agents; 2016 Mar 01; 30(3):733-741. PubMed ID: 27655490
    [Abstract] [Full Text] [Related]

  • 20. Detection and quantification of embolic particles during percutaneous coronary intervention to stable plaque: it correlates to coronary flow dynamics and myocardial damage.
    Okamura A, Ito H, Iwakura K, Kawano S, Kurotobi T, Date M, Inoue K, Ogihara T, Fujii K.
    Catheter Cardiovasc Interv; 2007 Feb 15; 69(3):425-31. PubMed ID: 17191241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.